XML 131 R104.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Financial Instruments were Denominated in U S Dollars (Detail)
$ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2024
CAD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
CAD ($)
Dec. 31, 2023
USD ($)
Jan. 01, 2023
CAD ($)
Disclosure of detailed information about financial instruments [Line Items]              
Cash     $ 73,771   $ 54,182   $ 21,587
Accounts receivable     378,712   421,427   413,925
Accounts payable and accrued liabilities     $ (314,355)   $ (350,749)   $ (404,350)
Canadian Operations [Member] | Currency Risk [Member]              
Disclosure of detailed information about financial instruments [Line Items]              
Cash       $ 3,084   $ 9,539  
Accounts receivable       2   17  
Accounts payable and accrued liabilities       (20,695)   (26,706)  
Net foreign currency exposure       (17,609)   (17,150)  
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on net earnings $ (176) $ (172)          
Foreign Operations [Member] | Currency Risk [Member]              
Disclosure of detailed information about financial instruments [Line Items]              
Cash       27,474   16,459  
Accounts receivable       113,400   148,885  
Accounts payable and accrued liabilities       (98,523)   (120,416)  
Long-term liabilities, excluding long-term incentive plans [1]       (5,197)   (13,708)  
Net foreign currency exposure       $ 37,154   $ 31,220  
Impact of $0.01 change in the U.S. dollar to Canadian dollar exchange rate on comprehensive income $ 372 $ 312          
[1] Excludes U.S. dollar long-term debt that has been designated as a hedge of the Corporation’s net investment in certain self-sustaining foreign operations.